首页 >
法规速递
-
Page: Stability testing for applications for variations to marketing authorisation - Scientific guideline-2025/12/12
2025-12-15查看详情 > -
国家药监局关于暂停进口、销售和使用Supriya Lifescience Ltd.马来酸氯苯那敏原料药的公告（2026年第14号） -2026/1/26
2026-01-27查看详情 > -
Document: Darwin EU study: Background incidence rates of selected vaccine adverse events of special in Europe-2026/3/4
2026-03-05查看详情 > -
Page: Paediatric addendum to the guideline on clinical investigation of medicinal products for the treatment of pulmonary arterial hypertension - Scientific guideline-2026/3/31
2026-04-01查看详情 > -
Development of Local Anesthetic Drug Products With Prolonged Duration of Effect-2026/5/13
2026-05-15查看详情 > -
Recommendations for Assessment of Blood Donor Eligibility, Donor Deferral and Blood Product Management in Response to Ebola Virus-2026/6/29
2026-06-30查看详情 > -
Document: Retinal stimulation systems - Notified Body 0344 - 12/06/2026 - Expert decision and opinion in the context of the clinical evaluation consultation procedure (CECP)-2026/8/4
2026-08-05查看详情 > -
Regulatory and procedural guideline: Concept Paper on the revision of Annex 11 of the guidelines on Good Manufacturing Practice for medicinal products – Computerised Systems-2022/11/16
2022-11-30查看详情 > -
国家药监局关于发布《已上市药品说明书增加儿童用药信息工作程序（试行）》的公告 （2023年第68号）-2023/5/31
2023-06-01查看详情 > -
国家药监局药审中心关于在药品审评检查长三角分中心、大湾区分中心增设对外受理服务窗口的通知-2023/11/29
2023-12-04查看详情 >
